Last updated on January 2019

Mucopolysaccharidosis (MPS) VI Clinical Surveillance Program (CSP)

Brief description of study

The objectives of this program are: to further characterize the natural progression of MPS VI disease; to generate and disseminate information on the care and management of MPS VI patients to clinical and medical professionals; to provide a resource to physicians and patients by providing information for optimizing patient care based on aggregate data; to characterize the clinical response to long-term Naglazyme (galsulfase) treatment; to further characterize the long-term safety of Naglazyme treatment.

Clinical Study Identifier: NCT00214773

Contact Investigators or Research Sites near you

Start Over

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.